ENESI
LIVE

Serial Number

79296907

Owner

Enesi Pharma Limited

Attorney

Rebecca Liebowitz

Filing Date

May 19, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ENESI Trademark

Serial Number: 79296907 • Registration: 6532792

ENESI is a trademark filed by Enesi Pharma Limited on May 19, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Enesi Pharma Limited (3 trademarks)

120 A&B Olympic Avenue,

Entity Type: 99

Trademark Details

Filing Date

May 19, 2020

Registration Date

October 26, 2021

Published for Opposition

August 10, 2021

Goods & Services

Pharmaceutical and veterinary preparations and substances for the treatment of and protection against infectious diseases; pharmaceutical and veterinary preparations and substances for the treatment of and protection against infectious and autoimmune disease; pharmaceutical and veterinary preparations and substances for the treatment of or protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; prophylactic pharmaceutical and veterinary preparations and substance for the treatment of infectious and autoimmune diseases; prophylactic pharmaceutical and veterinary preparations and substances against infectious and autoimmune diseases; vaccines, prophylactic vaccines, therapeutic vaccines; contraceptive preparations and substances

Surgical, medical, dental and veterinary apparatus and instruments, namely, needle-free drug administration devices sold empty; drug delivery devices for delivery of drugs; drug delivery apparatus for medical use, delivered through pressure; needle-free drug delivery systems sold empty; actuator devices drug delivery systems, namely, medical solid dose injector sold empty for injecting pharmaceutical and veterinary preparations into the skin; drug cassettes in the nature of drug and vaccine delivery systems sold empty; medical injectors, needle-free injectors sold empty; drug delivery devices, namely, medical injectors, needle-free injectors and parts and fittings therefore sold empty; actuator devices for use in drug delivery devices for use, namely, handheld spring-powered devices and handheld gas-powered devices, all in the nature of needle-free injection systems for injecting pharmaceutical and veterinary preparations into the skin sold empty; drug cassettes for use in drug delivery devices to contain pharmaceutical preparations and substances for therapeutic, prophylactic and diagnostic use; parts and fittings for all the aforesaid goods

Medical and veterinary research and development services; medical and veterinary device development services; pharmaceutical drug and vaccine development services; pharmaceutical drug and vaccine delivery system development services; preparation and/or formulation of pharmaceuticals, namely, pharmaceutical drug and vaccine development services; scientific research into vaccines; medical and veterinary device and product testing services; provision of information relating to the aforesaid services, namely, drug and vaccine development and drug and vaccine delivery technology; consultancy in relation to the aforesaid services, namely, drug and vaccine development and drug and vaccine delivery technology

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 3, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 12, 2022 FICS
FINAL DISPOSITION PROCESSED
Apr 12, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 26, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 26, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 10, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 10, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Aug 8, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 21, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 21, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 21, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 7, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 1, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 31, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 31, 2021 TROA
REFUSAL PROCESSED BY IB
Dec 20, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 29, 2020 RFCS
REFUSAL PROCESSED BY MPU
Nov 29, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 10, 2020 RFCR
NON-FINAL ACTION WRITTEN
Nov 9, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 6, 2020 MAFR
ASSIGNED TO EXAMINER
Nov 2, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 2, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 29, 2020 REPR